|
2023, Vol. 32(2): 99-105 DOI: 10.3760/cma.j.cn113030-20220228-00079 | ||
Analysis of LMP specific T cell immune response and clinical factors in stage III-IVa nasopharyngeal carcinoma | ||
Cui Haobo1, Chen Ting2, Fan Peiwen1, Wang Ruozheng1,2 | ||
1Key Laboratory of Tumor Immunology and Radiotherapy, Chinese Academy of Medical Sciences, Xinjiang Key Laboratory of Oncology, Wulumuqi 830011, China; 2Department of Head and Neck Comprehensive Radiation Oncology, the Affiliated Tumor Hospital of Xinjiang Medical University, Wulumuqi 830011, China |
||
Received 2022-02-28 Revised null | ||
Supporting info | ||
null | ||
|